Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 2, 2005

View Archived Issues

FDA approves first qualified health claim for chromium picolinate

Synthetic carotenoid reduces myocardial injury

Gadofosveset reported to improve diagnosis of aortoiliac vascular disease by MRA

Pharmasset earns milestone for Reverset study results

Pharmacopeia and Organon extend collaboration

Xechem creates U.K.-based subsidiary

WAY-209129: Novel perzinfotel derivative with increased oral activity and efficacy in pain models

BTG and Collegium Pharmaceutical to develop modified release product for asthma

German approval for modafinil for shift work sleep disorder

MIV-210 begins phase IIa study for HIV

Pharmexa licenses Biogen Idec's Provax adjuvant

YKP-3089 for anxiety cleared to enter clinical testing

sanofi-aventis extends research collaboration with ImmunoGen

CytRx to advance RIP140 siRNA for obesity and type 2 diabetes

New phase II study of Fodosine in advanced, fludarabine-refractory CLL

Forbes Medi-Tech submits IND for phase II study of cholesterol-lowering FM-VP4

Dimethaid planning name change to Nuvo Research

Daiichi Sankyo brand mark established

Novel antiarthritic agents claimed in recent patents

YM-230888: preclinical efficacy against cancer pain

Update on DG-041, a potential antiplatelet drug in clinical development

Eisai seeks U.S. approval for Aricept for severe Alzheimer's disease

A promising therapeutic for thromboembolic disorders reported by Mochida

Novel HIV protease inhibitors with nanomolar potency and once-daily dosing possibility

Fluarix approved in U.S.

Recent patents cover novel agents for respiratory disorders

Novel immunosuppressant agents claimed by 4 AZA Bioscience

Recent Teijin patent describes novel vitamin D3 receptor antagonists for bone diseases

Preliminary data suggest activity of topiramate in prevention of migraine and in tension headache

Teduglutide benefits short bowel syndrome patients in phase II study

Phase I trial results of alfimeprase in peripheral arterial occlusion reported

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...